GeneXplain GmbH has been founded in April 2010 and is based in Wolfenb眉ttel, Germany. The company aims at providing a comprehensive set of computational tools supporting the complete drug development pipeline from the statistical evaluation of high-throughput data, their biological interpretation, identification of potential targets to the prediction of most promising lead structures.
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
